Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I guess you are using TD Ameritrade They started this practice while BIEL were Caveat Emptor on Pinksheets.com and haven't changed their minds due to the transfer agent, yet many other stocks they do deal with using same agent!
The inability to buy with em means I still have some in my IRA I wanted to sell and buy back cheaper (bought around 0.08 I think) as FDA clearance will give a 0.10 price immediately overnight that I don't want to miss.
I have an Etrade account that trades no problem and have amassed a sizable number of shares at under 1.5c each by buying $300-$500 a month.
TDA have no real excuse, but I am sure if BIEL got off the pink sheets and onto the OTC BB proper they would change their minds.
from my perspective it is all about your investing style.
If you trade then you were out on the FR report, and should IMHO be considering getting back in once the price stabilizes - use some technical indicator to tell you this.
If you are an investor then I would be hanging in and looking to add soon but not until we see technical indicator and or some news.
The dilution is no where near what it was last year - they used to take $1m a month now it is $20k or so.
The gold they reported in the FR/PR may not have been sold yet. Most of it would have been processed in late Feb/march and then they will have c 60 days to get the cash - so we should expect them to still need operating funds to keep paying the workers and keeping commitments to the presidents in SL.
I expect to see this stop in May as the get the 100k. If we see any more dilution it is then a red flag. That may be the time to get back in or buy more unless we have FR by then.
I am puzzled why it takes so long to actually post a FR - surely a quick phone call (no need for email even) between Doug and John hen call the web master. It would be even better to get photos added but to convey what they wrote last week a call will do it.
why?
purely a potential take out candidate. Nothing to do with commodities as s far away from any production. (like this company will never do anything but the survey to prove they do have coal there.)
Success is a combination of the distribution model and the marketing /advertizing.
(actually four P's of marketing is still very true today after god knows how many years). Product Place Price Promotion.
Distribution and channels are part of Place and unfortunately BIEL had a distributor who didn't promote, but it sounds like did get to the shelves. BIEL then cancelled this and went for their own model through the web with better promotion through TV appearances on shows, and press articles - not mass advertising as it costs too much.
I believe they are having success and no I don't think Q4 was a good quarter as to many start up costs in UK as well as Canada but I am interested in numbers shipped.
Have they got it right now? I don't know but with every patch sold there is a new "Place" opened up through word of mouth!
I understand they have an international distributor lined up ready to take product once they get US FDA clearance. They may be able to move ahead of that, but will no doubt have to terminate any existing "exclusive" agreements they had for countries.
So in summary they haven't yet got all four P's going correctly at the same time - and it all costs money. I do think they have people who understand this now as over the last year better decisions IMO have been made.
how do you know they aren't making significant revenues?
we have no data for over 6 months now.
6 months ago they were starting their own (not a third party) distribution into Canada with press and TV appearances backed up with large inventory which damaged Q3 numbers.
Later that quarter they started the UK Allay campaign
I see no reason why they shouldn't be cash flow positive by now - something we should find out about later in May when Q1 numbers are released.
They have built up their staff both in marketing and logistics/manufacturing so hopefully they aren't all being paid in shares.
I am sure the company would be sold at a price above 0.50.
one more landmark for investors is upgrading to the true OTC BB and electronic trading (you cant buy it through TD Ameritrade at the moment as they deal in paper only).
It will spike on OTC but as set out by others and ideal scenario is phased with Q4 numbers showing shipments and some revenue, Q1 will show bigger numbers and real revenues and margins (Q4 was giving some away in UK).
They have in the past turned down offers at 0.70c a share but then diluted. I think I saw that they were offered 0.30 and laughed it as not enough.
Current valuation is absurd for a company that has real product and real markets, with TV and other promotion. Suffering from the J Noel pump and dump days unfortunately no one will get back in until numbers are seen.
With FDA approval I think we will see a rush of news flow as everything has been in place ready togo - distribution agreements, manufacturing ramp up etc all waiting fo a green light.
I will sell half at 0.30 -0.40c
Management has mentioned a number of times turning down offers as they were not insane enough.
The company is well positioned to exploit FDA approval with national distributors and financing in place ready for the word. See IR updates and other interviews for more.
I am sure there will be offers and probably a bidding war, can you say $1?
Current price is just insane based on international sales, once we get 10-K and the Q1 10-Q we will see prices around 0.10 on that business alone IMHO.
the FDA do not have a category that actipatch can be classified under yet, so they cannot approve them.
That is the "delay" and a lot of the time has been in BIEL making sure they provide all the data they can and answer all questions.
I am sure that if there were such a thing as a "stop clock" on the FDA they would have appeared to be pretty fast (for them).
Hopefully the De Novo process that defines the category of device as class II will also clear them for sale OTC - it doesn't have to.
If it fails to do that then there is something wrong with the FDA and big pharma's influence. But until then it is just doing its process.
the price hasnt really moved:
http://ih.advfn.com/p.php?pid=trades&symbol=mdhi
2 trades one at bid, one at ask!
2630 sold at 0.004
52000 bought at 0.0049
that is all that has happened on this news!
until a 10-k is posted by either company with audited and legal numbers no one will believe it!
The whole FDA process has been clouded by confusing and at times "not completely true" statements coming supposedly from teh company - especially back when Joe Noel ran the IR side of things.
If you look back to the statements from Andrew Whelan about the actual filing dates of applications, FDA responses (both unofficial meetings/calls and formal letters you will see that a lot of the delay has been on BIEL's side of the equation.
The whole process is at fault as anything that wasn't invented by 1978 has to apply, be rejected and then apply through the De Novo process for a new category of product. This has to then set the standards for any similar product in terms of defining the classification, the labeling and other measures necessary for class 2 or class 1 sales.
We are now in the final stage, but BIEL took 2 months to get their last information together.
it actually says 5 days if you read the second non-standard section where they explain the reason for the delay.
thanks guys for feedback re overburden
(why isn't there a threaded view here?)
So next year we will get to the virgin stuff earlier - good.
I read elsewhere there was daily silt that was delaying the start every day, can that be prevented/minimized in anyway? as they seem to only have 6 hours of production a day wasting one hour to get to where you were the day before is a lot of lost production.
How can the overburden be reduced?
I realize now how much of a problem the nightly and then seasonal burden of removing the sand and silt before getting to the virgin gravel. This IMHO is the reason for a lower than I expected number.
So how can this be minimized? Isn't there some sort of solution with tarpaulins? or leaving a "blower" running?
What area are we talking about - thinking more the nightly build up not seasonal?
new investor update:
http://bielcorp.com/investors/investor-updates/
Smart Insole released!
We are proud to introduce the Smart Insole™ – The Smart Insole is a miniaturized medical device that delivers continuous therapy to provide sustainable heel pain relief. The Smart Insole quickly relieves inflammation and pain, providing the patient comfort while reducing pain and speeding up the onset of natural healing. The kit includes an innovative miniature medical device embedded into a gel insole for daytime wear and a comfortable night time slipper to hold the Smart Insole in the evening.
The extended therapy provided by the Smart Insole maximizes sustained heel pain relief and dramatically accelerates healing. Heel pain or plantar fasciitis is a common persistent problem for runners and people who are on their feet most of the day. The U.S. market alone exceeds 10 million people. The Smart Insole will be available in a few days for purchase through our Canadian website www.actipatch.ca. If you would like to place an order now, please call our office at 1-866-757-2284.
Was that the web master?
buying 1,999,999 shares?
how long does it take to get a second mortgage and invest the cash?
I think people are most annoyed that there isn't any update for nearly 6 months. What happened to the Jan 15th date promised last year for production numbers?
From a financials view point we are waiting for Q4 2010 numbers not Q1 numbers.
I think the production figures for March are just a delaying tactic related to "forward looking statements" in the official 10K (for 2010) to coincide with a FR on the web site. I don't mind seeing these later if the financials are ready! I guess they are caught in a circle of what to put out when and not annoy SEC. No reason not to include production for Jan and Feb in the 10-K but then following with Q1 would give us the monthly figure - I have a feeling the months vary a lot so they don't want to show month by month numbers.
Expect Q1 financials (PR and 10-A) in late May/June.
Finances - and pricing of gold
Looking back through reports it seems that SGCP has pretty level expenditures through the year even though mining is very seasonal.
It seems that ANNUAL expenditures will be around $1.2m. in order to break even then they have to mine c 850 oz of gold (using c$1400 per oz). Is that a reasonable price for them to get? Is that a reasonable level of expense or has that gone up significantly due to agriculture?
How do they sell the gold they produce, is it done through some "wholesaler" who has to then process it into the more traditional forms - bars and coins before it hits the market at the advertised price? I am sure they don't get the listed price for the diamonds they find as they will be extremely rough, but the gold - how "pure" is it?
I am looking for the next report - which could have 5 or even 6 months figures to surpass this amount and show that SGCP can now be profitable - from just mining operations on an annual basis.
Is there any conclusive description of the agriculture activity and what its strategic purpose is?
reading the message board there are a number of strategic threads I can detect abut I am not sure which the Board of Directors have in mind.
a) it is a strategic side business to generate revenue for the company when dredging not happening (rainy season).
b) it is a hedge side business in case the gold and diamond isn't in the virgin deposits as originally thought. (IMHO this is the likely one as if there were gold and diamonds as you guys think some word would have got out by now from who they are selling it on to?)
c) it is to save the company money and secure the workforce by producing the wood and grain to feed and house the workers.
d) something else?
Thank you for that link - a great article and easy read fo ronce.
I particularly like this on page 4
so who gave them this line of credit?
Alex Trebek perhaps?
if numbers are so good where is the 10-K ?
just who buys Wordsmart? can they get it from their friends, elder children, school instead - ie is market already saturated?
The issue is the delay in getting a category of product defined that they can then be approved (or technically not approved) for.
The whole De Novo process is about defining product categories which define the type of warnings/labeling etc that products must have as well as what types of products fall in to that category - for example they are not TENS devices but I guess will define the electrical characteristics of such devices, the attachment, recommended hours of use etc.
Once defined I guess they will be rubber stamped into it but the FDA may say - you must now apply to be classified in the category you defined!
I am not waiting for FDA - just overseas numbers to start moving the stock to a realistic non-US market price. (c 10c IMHO)
I took the 8K to mean the past reports (10Q's for 2006-2009) would be by March 15th, not the current 10-K. Elsewhere Andy is quoted saying March 15th for current numbers but perhaps he got confused by the auditors as well.
As March 15th was Ides of March I am pleased they missed them but would like to see them today or tomorrow latest (with separate investor update).
There is nothing particularly suspicious in this.
MacLaren McCann are a large PR firm in Canada and I guess BIEL have a contract with them to run their advertising. They can get best rates for print and TV slots and it seems can also provide people to spin your products on TV for you. They will also create the materials for infomercials and print ads, manage video production etc.
This is standard lop level PR activity like major companies do. It just shows how professional BIEL is being and also potentially how much their cash flow has improved.
Otherwise they would have to fly brand managers from Maryland to the TV stations every time they wanted to talk Actipatch.
unfortunately the product is so revolutionary that BIEL fell into the procedure that is in place to stop stupid things being put forward.
They had to file for OTC clearance (and general prescription usage) and at the end of that process (quite a few months) were told "no significant equivalent product" (NSE) has been approved before (like you are unique) so you have to now file an NSE request to get a new category created. They could not do this initially (even though they suspected it) as that isn't how things are done!
As far as as I know from the reports from the company they have had discussions in detail about this including wordings to be used to describe the category and the controls (words) needed for the product. So there has been a lot of action with the FDA, but they don't seem to be a high priority that is for sure.
I think the next thing is that the NSE is accepted (creating a category) and I just hope they can then be stamped for approval and don't have to re-submit under the new category and wait more months.
The prescription request could be approved separately at anytime, there are a couple of trials underway to help its case.
In the mean time the company has pushed forward on all other fronts with I hope significant volumes shipped in Q4 and good revenues with higher volumes in Q1. This will show they can survive without the USA and price them I expect between .10 and .20.
FDA clearance on all fronts will then push the price at least temporarily neared .40 when they may get taken over.
they are sold through Amazon.com buy a Canadian based reseller.
The FDA has cleared the Rx variants for post operative usage and is available on prescription. the issue is to define a new category for these devices (they arent pain relief - like icy hot - but pain curing), so need different warnings usage instructions etc.
Once the category is defined then individual products can be cleared for OTC sales.
Other countries aren't as pedantic in their definitions or trial requests hence USA is the only place they aren't available, with CA and UK being targeted by direct marketing and new packaging since October 2010.
these were initial filings made to get the company inline with SEC reporting regulations ahead of hopefully an upgrade to OTCBB status.
There were a couple of amendments as the representation of Andrews shares through his wife's company etc is rather confusing even for them!
they are not recent purchases.
why do you think that a comercial run in the West Indies means it is running all over the world?
I am glad that there is a commercial though!
All it means that the cost of air time in the WI is very cheap. Could be testing the commercial for response rate - I guess there is a fairly large older population and also responsive medical networks to handle the MDHI product and associated calls for help.
You have to tune the message in the commercial a number of times to get optimum call ins - plus vary the network and time of showing before investing real money on air time. Takes 3-6 months at least.
This is all upfront cost that YESDTC is paying fro as far as I know, if they get it right (they have partners who are the real experts in this) , then they can make a lot of money but it is very much font loaded cost basis. After the commercial is tuned and test marketed for c 3 months the on going cost of air time should be covered by income,
I am expecting a Q4 loss based on the costs of so many new products (nutrifusion, Medipendent), but hopefully decent revenues from more mature products (Wordsmart).
Revenue means nothing. You can process all the $300 orders you want but if it costs you $310 to process you lose money.
YESDTC are in start up on many campaigns - lots of up front costs and payments for air time before any revenue comes in.
No proof yet that they can make any profit.
Profit is what we need not revenues.
BTW where is the proof of wordsmart being a $12m business?
read the updates and press release regarding Canada.
since the company took over the responsibility for distribution there (and in UK) from a third party they have been doing a lot of activity including TV appearances by brand managers.
There is a pharmacy distribution agreement in place which I think was starting in one location and now may be spreading out. These deals take time as you have to prove demand for product
the parallel DRTV, print ad and TV spots are perfect to keep awareness up and get sale off the shelves of pharmacy working.
Expect to see some numbers form DRTV and ads in Q4 numbers Q1 is where the pharmacy sales should start to happen.
Update sounded a bit like they have some issues in supply as well, which tied with the Scarsdale appointment is both pleasing (got sales higher than expected) but also worrying as they need to be able to supply much larger numbers once FDA is passed.
I don't think there was any deadline of 2-15. That is just basing things on last few quarters dates.
4th Qtr report will have a lot more data in it we hope so that takes time, plus working with the new auditors so I am expecting a week or more delay.
I'm waiting for my tax rebate so happy if stock stays around 1c for another week!
I'm not expecting blow away revenue numbers but do hope to see details of the quantity of devices shipped and "sold" to users.
The reason being the "sign up for regular shipping and get one free" promotion in the UK. I imagine this was successful - large numbers shipped but the revenue for repeat orders will not come in until next quarter.
not sure what the Canadian markets were doing.
Also some odd trading numbers today - lots of "sales" are the MM accumulating for a large buy order?
"FDA has approved other similar devices. For example, there are infomercials for devices that are supposed to exercise your abs with electrical stimulation. Not sure what the hold up is, especially with thousands of user data from around the world."
PEMF is completely different technology - you don't feel the pulses and the voltage is significantly LOWER. FDA has had to create a new classification for these devices.
BIEL do have a 'Gel less' TENS device (cant recall exact translation but to do with electronic nerve stimulation) which they are about to submit to FDA on basis it is similar to these other devices - in fact they used to market one years ago. Strategy is to get that apporved and then say - "hang on if this is OK why isn't something at 1% the voltage?"
TD Ameritrade stopped dealing in BIEL - to be precise they stopped dealing with their handling agent about 18 months ago as it is too expensive to trade with paper certificates.
They will still sell your shares but you cannot buy any. I don't see this changing until they upgrade their handling agent as part of moving to the true OTC BB market. This is something I hope Scaresdale are helping with.
I don't know of any other company that posts investor updates on a schedule like this, it is just in the last 2 weeks they havent started any new campaigns etc.
It does indicate what they have been up to though
Earnings will be announced around Feb 16th looking back at previous Q reporting dates. that is the only report they have to make and is where you will see numbers. They will not publish numbers on this update section of the web site before submitting the SEC forms.